Table III.

Evaluation of 12 selected miRNAs using sRNA sequencing and RT-qPCR methods.

miRNA	Malignant vs. benign OGCTsa			Malignant OGCTs vs. SCSTsb			Benign OGCTs vs. SCSTsb
	sRNA seq	RT-qPCR	Concordance	sRNA seq	RT-qPCR	Concordance	sRNA seq	RT-qPCR	Concordance
miR-372-3p	Higher	Higher	Yes	Higher	Higher	Yes	Equal	Equal	Yes
miR-373-3p	Higher	Higher	Yes	Higher	Higher	Yes	Equal	Equal	Yes
miR-302c-3p	Higher	Higher	Yes	Higher	Higher	Yes	Higher	Equal	No
miR-199a-5p	Lower	Lower	Yes	Lower	Lower	Yes	Equal	Equal	Yes
miR-214-5p	Lower	Lower	Yes	Lower	Lower	Yes	Equal	Equal	Yes
miR-202-3p	Lower	Lower	Yes	Lower	Lower	Yes	Lower	Lower	Yes
miR-513c-5p	Equal	Lower	No	Lower	Lower	Yes	Lower	Lower	Yes
let-7f	Lower	Equal	No	Lower	Equal	No	Equal	Equal	Yes
miR-21	Equal	Equal	Yes	Higher	Equal	No	Equal	Equal	Yes
miR-34a	Higher	Equal	No	Higher	Equal	No	Equal	Equal	Yes
miR-125a-5p	Equal	Equal	Yes	Lower	Equal	No	Equal	Equal	Yes
miR-193a-3p	Higher	Equal	No	Higher	Equal	No	Higher	Equal	No

^aHigher and lower refer to expression in the malignant OGCTs compared to the benign OGCTs.

^bHigher and lower refer to expression in malignant or benign OGCTs as compared to SCSTs. miRNA, microRNA; OGCT, ovarian germ cell tumor; SCST, sex cord stromal tumor; sRNA seq, small RNA sequencing; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.